Vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for patients with Grade 2 gliomas with IDH1 or IDH2 mutations.
Dana-Farber Cancer InstituteAug 6 2024 Vorasidenib has been approved by the U.S. Food and Drug Administration for patients with Grade 2 gliomas with IDH1 or IDH2 mutations.
Patrick Y. Wen, MD, Director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute and one of the trial's three study chairs "These patients are often young, in their 30s or 40s. But ten to twenty years later, even if they are doing well from the point of their tumor, they often show signs of dementia after radiation and chemotherapy," says Wen. "If this medicine can delay the start of these treatments, it would delay cognitive dysfunction in patients and preserve their quality of life."
Cancer Chemotherapy Children Clinical Trial Food Gliomas Hospital Mutation Neuro-Oncology Oncology Placebo Research Surgery Tumor
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Proteogenomics analysis of high-grade gliomas offers hints on tumor evolutionIn August 2023, a team of researchers including Dr. Eduard Porta, group leader at the Josep Carreras Institute, published a thorough analysis of the effects of cancer driver alterations found across different cancer types, ranging from epigenetic dysregulation to protein-protein interactions.
Read more »
Plan to turn Grade II listed Frogmore House into 'school'New plans could see the 300-year-old Grade II listed Frogmore House building in Watford become a 'school'.
Read more »
Take a look inside this Grade II listed stone-built house that has hit the marketThis captivating, stone-built property with historic charm and features dating back to the 14th century has hit the market for just £600,000.
Read more »
From Dr. Oz to heart valves: A tiny device charted a contentious path through the FDAIn 2013, the FDA approved an implantable device to treat leaky heart valves. Among its inventors was Mehmet Oz, the former television personality and former U.S. Senate candidate widely known as 'Dr. Oz.'
Read more »
There’s Now an FDA-Approved Blood Test for Colon CancerThe first-of-its-kind blood test offers a new way of screening for a leading cause of cancer deaths.
Read more »
FDA warns of accidental overdoses from compounded versions of OzempicPeople taking compounded versions of Ozempic have been overdosing on the drug, the U.S. Food and Drug Administration warns.
Read more »